Billionaires Are Selling Philip Morris International and Loading the Boat on This “Magnificent Seven” Stock.

  • Philip Morris International has had a strong year, but the stock has suffered since July on concerns about demand for the company’s Zyn non-smoking products.

  • The tobacco company still pays a relatively high dividend.

  • Several billionaires bought one specific “Magnificent Seven” stock in the third quarter.

  • 10 stocks we like better than Alphabet ›

It’s understandable why retail investors might see a hedge fund make a big new investment in a company and bet on that stock. After all, billionaire hedge fund managers are generally considered the best stock pickers on Wall Street, and some of them even have the investment returns to back up that premise.

But retail investors should remember that, in general, they are finding out about these businesses a few months after they happen, and many hedge funds invest for short-term time horizons. This is why retail investors should always perform their own due diligence to ensure that it still makes sense to buy a particular stock.

However, if several billionaire hedge fund managers are buying or selling the same stock, it can be a clear indicator that it is at least time to take a look at how they follow their lead. In the third quarter, a number of billionaires sold their shares Philip Morris International (NYSE:PM) and loaded on one “Magnificent Seven” stock.

Image source: Alphabet.

Shares in tobacco giant Philip Morris are having a strong year. They’re up 27% since Nov. 17, but the stock was doing even better before — it’s since given up some ground since July. And the period from July to September was when a couple of billionaires got out of their shares in the company:

  • Stanley Druckenmiller’s Duquesne Family Office sold nearly all of its 816,000 shares.

  • Philippe Laffont’s Coatue Management also fully exited its position in Philip Morris, selling nearly 1.3 million shares.

The stock’s slide began after Philip Morris released its second-quarter earnings report. Its earnings were stronger than expected, and management raised its forecast for the full year. However, revenue came in below expectations, and investors grew concerned about demand for the company’s new smokeless nicotine pouch product, Zyn. Demand was still strong, but because Zyn is seen as the future of the cigarette-focused company for a long time, investors are focused on its growth.

Investors were disappointed again after Philip Morris gave its third quarter results at the end of October. Management said it has been involved in some promotions for Zyn, which has led some onlookers to question how sustainable the product moat can be in a world filled with increasing competition. Still, net income in the company’s smokeless business grew 17.7% year over year in the quarter.

Leave a Comment